Randomized comparison of intra-arterial and intravenous thrombolysis in a canine model of acute basilar artery thrombosis

Neuroradiology

Volumn 46, Issue 12, 2004, Pages 988-995

  Qureshi, A I ^a   Boulos, A S ^b   Hanel, R A ^b   Suri, M F K ^b   Yahia, A M ^a   Alberico, R A ^c   Hopkins, L N ^b  

^a NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Basilar artery; Canine; Ischemic stroke; Thrombolysis; Thrombosis

Indexed keywords

ALTEPLASE; PLACEBO; RETEPLASE;

ACUTE DISEASE; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BASILAR ARTERY; BLOOD CLOT; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION; CATHETERIZATION; CONTROLLED STUDY; DOG; DRUG DOSE REGIMEN; FEMALE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZATION; RECANALIZATION; STATISTICAL SIGNIFICANCE;

ANIMALS; BASILAR ARTERY; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOGS; FEMALE; FIBRINOLYTIC AGENTS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; INTRACRANIAL THROMBOSIS; MALE; RANDOM ALLOCATION; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 20444450602     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1180-8     Document Type: Article

References (28)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581-1587 10.1056/NEJM199512143332401
2. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA (2000) Intravenous tissue-type plasminogen activator for treatment of acute stroke: The standard treatment with alteplase to reverse stroke (STARS) study. JAMA 283: 1145-1150 10.1001/jama.283.9.1145
3. Hacke W, Kaste M, Fieschi C, et al (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352: 1245-1251 10.1016/S0140-6736(98)08020-9
4. Furlan A, Higashida R, Wechsler L, et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. JAMA 282: 2003-2011 10.1001/jama.282.21.2003
5. Qureshi AI, Ringer AJ, Suri MF, Guterman LR, Hopkins LN (2000) Acute interventions for ischemic stroke: Present status and future directions. J Endovasc Ther 7: 423-428 10.1583/ 1545-1550(2000)007<0423:AIFISP>2.0.CO;2
6. Adams HP Jr, Brott TG, Furlan AJ, et al (1996) Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94: 1167-1174 8790069
7. Suárez JI, Sunshine JL, Tarr R, et al (1999) Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30: 2094-2100 10512912
8. Ueda T, Sakaki S, Kumon Y, Ohta S (1999) Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30: 2360-2365 1:STN:280:DC%2BD3c%2FhvVemtA%3D%3D
9. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M (1998) PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 29: 4-11 9445320
10. Qureshi AI, Ali Z, Suri MF, et al (2001) Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 49: 41-50 10.1097/00006123-200107000-00006
11. Qureshi AI, Siddiqui AM, Suri MF, et al (2002) Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study. Neurosurgery 51: 1319-1329 10.1097/00006123-200211000-00040
12. Noble S, McTavish D (1996) Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 52: 589-605 1:CAS:528:DyaK28XmsVaisr0%3D
13. Qureshi AI, Pande RU, Kim SH, Hanel RA, Kirmani JF, Yahia AM (2002) Third-generation thrombolytics for treatment of ischemic stroke. Current Opin Invest Drugs 3: 1729-1732 1:CAS:528:DC%2BD3sXhtlKktLo%3D
14. Seldinger S (1953) Catheter replacement of the needle in percutaneous angiography: A new technique. Acta Radiol 39: 368-376 1:STN:280:CyyD1c3mtVE%3D
15. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators (1997) A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337: 1118-1123 10.1056/ NEJM199710163371603
16. Bode C, Smalling RW, Berg G, et al (1996) Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation 94: 891-898 1:STN:280:BymA1c3hsFw%3D
17. Smalling RW, Bode C, Kalbfleisch J, et al (1995) More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 91: 2725-2732 1:STN:280:ByqB2sjpt1Y%3D
18. Takano K, Carano RA, Tatlisumak T, et al (1998) Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology 50: 870-875 1:CAS:528:DyaK1cXivVajtrY%3D
19. Martin U, Dorge L, Fischer S (1996) Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis. Br J Pharmacol 118: 271-276 1:CAS:528:DyaK28Xjt1Ojur0%3D
20. Martin U, Kohnert U, Stern A, Popp F, Fischer S (1996) Comparison of the recombinant Escherichia coli-produced protease domain of tissue-type plasminogen activator with alteplase, reteplase and streptokinase in a canine model of coronary artery thrombolysis. Thromb Haemostasis 76: 1096-1101 1:CAS:528:DyaK2sXjvVCmsw%3D%3D
21. Martin U, Kaufmann B, Neugebauer G (1999) Current clinical use of reteplase for thrombolysis. A pharmacokinetic-pharmacodynamic perspective. Clin Pharmacokin 36: 265-276 10320949
22. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R (1995) Fibrinolytic therapy for acute embolic stroke: Intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 36: 246-253 1:STN:280:ByqB2cbgsFI%3D
23. Lee VM, Burdett NG, Carpenter A, et al (1996) Evolution of photochemically induced focal cerebral ischemia in the rat. Magnetic resonance imaging and histology. Stroke 27: 2110-2119 1:STN:280:ByiD2Mvlt1M%3D
24. Moseley ME, Kucharczyk J, Mintorovitch J, et al (1990) Diffusion-weighted MR imaging of acute stroke: Correlation with T2- weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR 11: 423-429 1:STN:280:By%2BB2szptVY%3D
25. Gustafsson O, Rossitti S, Ericsson A, Raininko R (1999) MR imaging of experimentally induced intracranial hemorrhage in rabbits during the first 6 hours. Acta Radiol 40: 360-368 1:STN:280:DyaK1MzitVOrtw%3D%3D
26. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K (1999) A standardized MRI stroke protocol: Comparison with CT in hyperacute intracerebral hemorrhage. Stroke 30: 765-768 1:STN:280:DyaK1M3gsFehuw%3D%3D
27. Boyko OB, Alston SR, Fuller GN, Hulette CM, Johnson GA, Burger PC (1994) Utility of postmortem magnetic resonance imaging in clinical neuropathology. Arch Pathol Lab Med 118: 219-225 1:STN:280:ByuC1czgt1w%3D
28. De Groot CJ, Bergers E, Kamphorst W, et al (2001) Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain 124: 1635-1645 10.1093/ brain/124.8.1635